Orem, UT - June 9, 2026 - DietsMD.com, an online medical weight loss platform specializing in doctor-guided GLP-1 ...

But with GLP-1 drugs, she said, “everyone is kind of iterating in real time.” Here’s what we’ve learned in the process. At ...

An endocrinologist’s new weight-care system halted population-level weight gain and could reshape obesity treatment across ...

Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

Eli Lilly’s highly anticipated new weight loss drug, retatrutide, helped people lose up to 30% of their body weight, about 85 pounds, in a late-stage clinical trial, the drugmaker said in a news ...

Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

The next generation of glucagonlike peptide 1 (GLP-1) weight-loss drugs has taken another step forward to U.S. Food and Drug Administration approval. In new clinical trial results from the ...

MEDVi is a telehealth platform offering GLP-1 weight loss medications, including both FDA-approved and compounded versions. Monthly costs vary, with compounded medications starting at $179 and ...

What you should know about the federal government’s pilot program offering GLP-1s solely for weight loss. By Mark Miller Millions of older Americans may have access for the first time to obesity drugs ...